Vita Life Sciences Limited reported unaudited sales results for the six months ended June 2013. For the period, sales were approximately $17 million, an increase of 18% from $14.4 million for the previous corresponding period.

For the six months, EBIT is expected to be between $2.3 million and $2.4 million, up 113% from the June half in 2012.